Can Kailera become the next major GLP-1 challenger after pricing one of biotech’s biggest IPOs in years?
UCB SA (EBR: UCB) bets $1.15 bn on Neurona Therapeutics to push epilepsy treatment beyond symptom control
Read More Technology Industry News Windyty acquires majority stake in Meteoblue to boost global weather forecasting services In a significant development in the global weather forecasting industry, Windyty, S.E., known for its popular weather platform… byPallavi MadhirajuJune 13, 2024